Whole-exome sequencing of long-term, never relapse exceptional responders of trastuzumab-treated HER2+ metastatic breast cancer

Naomi Walsh, Charlotte Andrieu, Peter O’Donovan, Cecily Quinn, Alanna Maguire, Simon J. Furney, Giuseppe Gullo, John Crown

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Whole-exome sequencing of long-term, never relapse exceptional responders of trastuzumab-treated HER2+ metastatic breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences